BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10455370)

  • 1. Thrombotic microangiopathy following allogeneic bone marrow transplantation.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 1999 Aug; 24(3):303-6. PubMed ID: 10455370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome.
    Takatsuka H; Takemoto Y; Yamada S; Wada H; Tamura S; Fujimori Y; Okamoto T; Suehiro A; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 2000 Aug; 26(4):419-26. PubMed ID: 10982289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral eicosapentaenoic acid for complications of bone marrow transplantation.
    Takatsuka H; Takemoto Y; Iwata N; Suehiro A; Hamano T; Okamoto T; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 2001 Oct; 28(8):769-74. PubMed ID: 11781629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?
    Llamas P; Romero R; Cabrera R; Sanjuán I; Forés R; Fernández MN
    Bone Marrow Transplant; 1997 Aug; 20(4):305-6. PubMed ID: 9285545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathy following bone marrow transplantation.
    Pettitt AR; Clark RE
    Bone Marrow Transplant; 1994 Oct; 14(4):495-504. PubMed ID: 7858524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
    Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
    Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.
    Nishida T; Hamaguchi M; Hirabayashi N; Haneda M; Terakura S; Atsuta Y; Imagama S; Kanie T; Murata M; Taji H; Suzuki R; Morishita Y; Kodera Y
    Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Yamada S; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 1999 Nov; 24(9):1005-7. PubMed ID: 10556960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO).
    Iacopino P; Pucci G; Arcese W; Bosi A; Falda M; Locatelli F; Marenco P; Miniero R; Morabito F; Rossetti F; Sica S; Uderzo C; Bacigalupo A
    Bone Marrow Transplant; 1999 Jul; 24(1):47-51. PubMed ID: 10435734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of cytokines during the course of graft-versus-host disease following bone marrow transplantation: a case report.
    Takatsuka H; Takemoto Y; Okada M; Sawada A; Katsuno T; Wada H; Kakishita E
    Cytokine; 2000 Aug; 12(8):1225-7. PubMed ID: 10930300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fulminant angiopathy caused by allogenic transplantation of bone marrow with cerebral involvement: clinico-pathologic correlation].
    Guerrero AL; Pérez-Simón JA; Cuñado A; Cacho J; Vidriales B
    An Med Interna; 1998 Oct; 15(10):545-7. PubMed ID: 9844232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies.
    Natazuka T; Kajimoto K; Ogawa R; Imoto S; Koizumi T; Nishimura R; Nakagawa T
    Bone Marrow Transplant; 1998 Apr; 21(8):815-9. PubMed ID: 9603406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy.
    Copelan EA; Penza SL; Theil KS; Elder PJ; Bechtel TP; Tighe MB; Ezzone SA; Scholl MD; Belt PS; Young DC; Avalos BR
    Bone Marrow Transplant; 2000 Nov; 26(10):1037-43. PubMed ID: 11108300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Requirements for early discharge after allogeneic bone marrow transplantation].
    Yasumi M; Karasuno T; Kanashima H; Masaie H; Taniguchi H; Mitsui H; Nakamura H; Hiraoka A
    Rinsho Ketsueki; 2001 Aug; 42(8):601-9. PubMed ID: 11579498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes.
    George JN; Selby GB
    Bone Marrow Transplant; 2004 Jun; 33(11):1073-4. PubMed ID: 15153944
    [No Abstract]   [Full Text] [Related]  

  • 20. Microangiopathy without hemolysis in a patient following allogeneic bone marrow transplantation.
    Akiyama H; Yoshinaga H; Endou M; Tanikawa S; Sakamaki H; Tanoue K; Onozawa Y
    Bone Marrow Transplant; 1997 Aug; 20(3):261-3. PubMed ID: 9257898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.